Catherine Benoist-Lasselin

Author

Inserm ORCID

Also Known As

C Benoist-Lasselin, C. Benoist-Lasselin, C. Lasselin-Benoist, Catherine Benoist-Lasselin

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Inserm Université Paris Cité Hôpital Necker-Enfants Malades Assistance Publique – Hôpitaux de Paris Centre National de la Recherche Scientifique

About

Catherine Benoist-Lasselin is an author at Inserm specializing in medicine, cell biology, and developmental biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.1K
2	Health Sciences	1	1	37
3	Natural Sciences	1	1	59
4	Biochemistry	1	1	59
5	Biomedical Engineering	1	1	199

Catherine Benoist-Lasselin

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
ADAMTS10 Mutations in Autosomal Recessive Weill-Marchesani Syndrome Nathalie Dagoneau, Catherine Benoist-Lasselin, Céline Huber, The American Journal of Human Genetics Mendelian DisorderGenetic DisorderGeneticsAdamts10 MutationsGenetic Epidemiology	2004	278
Evaluation of the Therapeutic Potential of a CNP Analog in a Fgfr3 Mouse Model Recapitulating Achondroplasia Florence Lorget, Nabil Kaci, Jeff Peng, The American Journal of Human Genetics Regenerative MedicineTherapeutic PotentialCnp AnalogFibroblast Growth FactorCytoskeleton	2012	199
Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification Anne‐Lise Delezoide, Catherine Benoist-Lasselin, Laurence Legeai‐Mallet, Mechanisms of Development MechanobiologyDevelopmental BiologySpatio-temporal ExpressionBone Morphogenic ProteinFgfr 1	1998	177
Fibroblast Growth Factor Receptor 3 Mutations Promote Apoptosis but Do Not Alter Chondrocyte Proliferation in Thanatophoric Dysplasia Laurence Legeai‐Mallet, Catherine Benoist-Lasselin, Anne‐Lise Delezoide, Journal of Biological Chemistry	1998	137
Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model Davide Komla‐Ebri, Emilie Dambroise, Ina Krämer, Journal of Clinical Investigation Fgfr3-related DwarfismExcessive Fgfr3 ActivationDevelopmental BiologyPan-fgfr TkiBone Morphogenic Protein	2016	106
Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias Laurence Legeai‐Mallet, Catherine Benoist-Lasselin, A Munnich, Bone Musculoskeletal ResearchDevelopmental BiologyBone Morphogenic ProteinGeneticsPathology	2003	105
FGFR3 mutation causes abnormal membranous ossification in achondroplasia Federico Di Rocco, Martin Biosse Duplan, Yann Heuzé, Human Molecular Genetics	2014	84
Mutations in the basic domain and the loop–helix II junction of TWIST abolish DNA binding in Saethre–Chotzen syndrome Vincent El Ghouzzi, Laurence Legeai‐Mallet, Catherine Benoist-Lasselin, FEBS Letters	2001	65
Synthesis and biological evaluation of a triazole-based library of pyrido[2,3-d]pyrimidines as FGFR3 tyrosine kinase inhibitors Laurent Le Corre, Anne‐Lise Girard, J Aubertin, Organic & Biomolecular Chemistry Combinatorial ChemistryBioorganic ChemistryPharmaceutical ChemistryMedicinal ChemistryReceptor Tyrosine Kinase	2010	59
Defective chondrocyte proliferation and differentiation in osteochondromas of MHE patients Catherine Benoist-Lasselin, Emmanuel de Margerie, Linda Gibbs, Bone Regenerative MedicineBone DiseaseBone Morphogenic ProteinOsteoarthritisPathology	2006	51

Page 1